AOMR financial statements and SEC filings
AOMR annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | – | – | $44.02M | 10-K |
| 2024-12-31 | – | – | $28.75M | 10-K |
| 2023-12-31 | – | – | $33.71M | 10-K |
| 2022-12-31 | – | – | -$187.85M | 10-K |
| 2021-12-31 | $41.76M | – | $21.10M | 10-K |
| 2020-12-31 | $10.38M | – | $721.00K | 10-K |
AOMR annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $2.75B | $2.48B | $267.52M | 10-Q |
| 2024-12-31 | $2.27B | $2.03B | $238.97M | 10-K |
| 2023-12-31 | $2.31B | $2.05B | $256.11M | 10-K |
| 2022-12-31 | $2.95B | $2.71B | $236.48M | 10-K |
| 2021-12-31 | $2.58B | $2.09B | $491.39M | 10-K |
| 2020-12-31 | $509.66M | $261.35M | $248.31M | 10-K |
AOMR annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$406.95M | – | $395.68M | 10-K |
| 2024-12-31 | -$221.47M | – | $99.32M | 10-K |
| 2023-12-31 | $306.40M | – | -$107.66M | 10-K |
| 2022-12-31 | -$331.13M | – | -$345.65M | 10-K |
| 2021-12-31 | -$1.57B | – | $2.03B | 10-K |
| 2020-12-31 | $34.41M | – | $54.80M | 10-K |